Advisor Profiles

Gilly Stoddart, PhD
Dr. Gilly Stoddart is a director of the Science Consortium and is also the director of PETA UK’s Science Department. She has a PhD in drug delivery from the Cardiff University and has seven years experience working in research and development. Dr. Stoddart serves as the Consortium’s point of contact for the European Chemicals Agency. For six years, she was a member of the UK Animals in Science Committee which advises the Secretary of State on all matters concerning the use of animals in scientific procedures.

Amy Clippinger, PhD
Dr. Amy Clippinger is the president of the Science Consortium and is also director of the PETA US Regulatory Testing Department. She has a PhD in cellular and molecular biology and genetics and conducted her post-doctoral research in the Cancer Biology Department at the University of Pennsylvania. She is a Past President of the Society of Toxicology In Vitro and Alternative Methods Specialty Section, and a member of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) that advises the US Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the US National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).

Julia Baines, PhD
Dr. Julia Baines has a PhD from the University of Liverpool with a background in animal behaviour and welfare and has lectured for many years on animal ethics, law, and philosophy. Dr. Baines advises the Science Consortium on strategies to minimise the use of animals under the Registration, Evaluation and Authorisation of Chemicals (REACH) regulatory framework, communicating with the European Commission and European Parliament, and representing the Science Consortium as a European Chemicals Agency-accredited stakeholder organisation.

Paula Braun, PhD
Dr. Paula Braun has a PhD in biochemistry from the Weizmann Institute of Science and has many years of experience working towards the research, development, and validation of novel in vitro testing methods. She advises the Science Consortium on animal testing and non-animal methods, particularly for genotoxicity testing.

Jeffrey Brown
Jeffrey Brown studied epidemiology and public health at George Washington University after receiving his undergraduate degree in cell and molecular biology. He advises the Science Consortium on animal-free approaches to assess the toxicity of medical devices and biologicals.

Christopher Fassbender, PhD
Dr. Christopher Fassbender has a PhD in biology and several years of research and teaching experience in ecotoxicology and zoology at the University of Heidelberg. At the international level, Dr. Fassbender advises the Science Consortium on animal testing and alternative methods with regard to toxicology and ecotoxicology regulations and guidance at the Organisation for Economic Co-Operation and Development and the European Chemicals Agency.

Katherine Groff, MS
Katherine Groff has an undergraduate degree in biology from the University of Notre Dame and a master’s degree from Michigan State University in natural resource management, with a focus on policy. Before coming to PETA US, she had more than a decade of experience in animal welfare and environmental policy.

Gina Hilton, PhD
Dr. Gina Hilton has a PhD in Toxicology from North Carolina State University, and a MS in Chemistry from Wake Forest University. Her PhD research focused on using ‘omic based approaches to assess the utility of co-culture models of the respiratory track to predict toxicity following nanomaterial exposure. Dr. Hilton advises the Science Consortium on the development and implementation of in silico and in vitro testing strategies.

Janneke Hogervorst, PhD
Dr. Janneke Hogervorst has a PhD in cancer epidemiology from Maastricht University. She held postdoctoral positions in and lectured on cancer epidemiology at Maastricht University and environmental health epidemiology at Hasselt University. Dr. Hogervorst advises the Science Consortium on the replacement of animal testing in the Netherlands.

Kimberley Jayne, PhD
Dr. Kimberley Jayne has a PhD in animal behaviour from the University of Exeter. She engages with policy- and decision-makers in the UK and advises the Science Consortium on strategies for the implementation of animal-free research methods. She has particular expertise in behavioural testing.

Emily McIvor, MA
Emily McIvor has an undergraduate degree in English and Politics from the University of York, and a Postgraduate Certificate of Education from the University of Exeter. She is an EU policy expert with more than twenty years’ experience and serves as Science Policy Advisor for PETA UK. Ms. McIvor is a member of the Mirror Group of the European Partnership for Alternatives to Animal Testing, and contributed to the European Commission’s Technical Expert Working Group during negotiation of Directive 2010/63 EU on the protection of animals used for scientific purposes. In 2012, Ms. McIvor received the Henry Spira Award for her contribution to animal welfare, and in 2013 she was awarded the Lush Special Prize celebrating implementation of the EU ban on the sale of newly animal tested cosmetics.

April Naab, MS
April Naab has a master’s degree in chemical engineering from Montana State University. Her thesis work involved the characterisation of pharmaceutically relevant polymers using nuclear magnetic resonance, and after graduation, she spent several years working in the pharmaceutical industry. She advises the Science Consortium on pharmaceutical regulations and the minimisation of animal use during preclinical testing.

Andrew Nguyen, PhD
Dr. Andrew Nguyen has a PhD in Biology from the University of Vermont and several years of research experience at the University of Florida. He advises the Science Consortium on non-animal methods for testing food and medical devices and on the use of in silico models.

Ankita Pandey, PhD
Dr. Ankita Pandey serves as a Research Associate at PETA India where she works with various Indian regulatory agencies to promote the implementation and regulatory acceptance of non-animal test methods. She has a PhD in Zoology from Maharishi University of Information Technology. Her PhD work at CSIR-Indian Institute of Toxicology Research focused on developing stem cell-based high-throughput in vitro systems to assess the neurotoxicity and developmental neurotoxicity potential of drugs and chemicals.

Erik Prochazka, MS
Erik Prochazka has an undergraduate degree in Environmental Health Science and a master’s degree in Environmental Science from Griffith University, both with a strong focus on environmental toxicology and human health risk assessment. Prior to joining PETA UK, Erik dedicated his efforts to the development and validation of novel in vitro testing methods and strategies used in toxicology, and to their application for chemical hazard and risk assessment. He advises the Science Consortium on EU regulatory testing issues.

Bridget Rogers, MS
Bridget Rogers has an undergraduate degree in Biological Sciences from Louisiana State University and a Master of Science in Global Health from Duke University. She previously worked for the state of Louisiana in environmental regulation and has toxicology laboratory experience. She advises the Science Consortium on public and global health as well as regulatory toxicology testing.

Monita Sharma, PhD
Dr. Monita Sharma received her PhD in biomedical sciences from Wright State University with nanotoxicology as the main area of focus. Her thesis work, conducted in collaboration with Wright Patterson Air Force Base, involved evaluation of the immunological implications of exposure to gold nanoparticles and development of a dynamic in vitro blood brain barrier co-culture model for the testing of nanomaterials. As the nanotoxicology specialist for the Science Consortium, Dr. Sharma researches and promotes human-relevant non-animal methods to assess nanotoxicity. Dr. Sharma participates on the International Organization for Standardization (ISO) Technical Committee on nanotechnology and the Organisation for Economic Co-operation and Development Working Party for Manufactured Nanomaterials (OECD WPMN) to ensure the best non-animal methods are included in international standards and guidelines for nanomaterial testing.

Andreas Stucki, PhD
Dr. Andreas Stucki has a PhD in biomedical sciences from the University of Bern where he was involved in the development and biological validation of a lung-on-a-chip—an advanced in vitro model of the human air-blood barrier. Dr. Stucki advises the Science Consortium on inhalation toxicity and nanomaterial testing issues.

Mandy Veillette, BSc, LLB, MSc
Mandy Veillette has an undergraduate degree in animal biology from McGill University, a law degree from the University of Montréal, and a master’s degree in environmental sciences from Université du Québec à Montréal. She advises the Science Consortium on REACH, the Cosmetics Regulation and other regulations of interest, and the EU Chemicals Strategy for Sustainability.​

Anna van der Zalm, MS
Anna van der Zalm has a master’s degree in Chemistry from the University of Oxford. Her master’s thesis focused on using biophysical and in vitro techniques to study chaperone proteins involved in pathways that cause Alzheimer’s. She advises the Science Consortium on strategies to minimise the use of animals under international plant protection product legislation.